242 related articles for article (PubMed ID: 30673663)
1. The Role of MRI Biomarkers and Their Interactions with Cognitive Status and APOE ε4 in Nondemented Elderly Subjects.
Liang X; Yin Z; Liu R; Zhao H; Wu S; Lu J; Qing Z; Wei Y; Yang Q; Zhu B; Xu Y; Zhang B
Neurodegener Dis; 2018; 18(5-6):270-280. PubMed ID: 30673663
[TBL] [Abstract][Full Text] [Related]
2. Automated Hippocampal Subfield Measures as Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease in Two Independent Cohorts.
Khan W; Westman E; Jones N; Wahlund LO; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Lovestone S; Muehlboeck JS; Simmons A;
Brain Topogr; 2015 Sep; 28(5):746-759. PubMed ID: 25370484
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people.
Shen S; Zhou W; Chen X; Zhang J;
Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429
[TBL] [Abstract][Full Text] [Related]
4. Disrupted Brain Structural Connectivity: Pathological Interactions Between Genetic APOE ε4 Status and Developed MCI Condition.
Ma C; Wang J; Zhang J; Chen K; Li X; Shu N; Chen Y; Liu Z; Zhang Z
Mol Neurobiol; 2017 Nov; 54(9):6999-7007. PubMed ID: 27785756
[TBL] [Abstract][Full Text] [Related]
5. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
6. The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.
Cao J; Tang Y; Chen S; Yu S; Wan K; Yin W; Zhen W; Zhao W; Zhou X; Zhu X; Sun Z
J Alzheimers Dis; 2024; 98(3):907-923. PubMed ID: 38489180
[TBL] [Abstract][Full Text] [Related]
7. Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer's disease.
Qu H; Ge H; Wang L; Wang W; Hu C
Acta Neurol Belg; 2023 Aug; 123(4):1381-1393. PubMed ID: 37043115
[TBL] [Abstract][Full Text] [Related]
8. MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
Ten Kate M; Redolfi A; Peira E; Bos I; Vos SJ; Vandenberghe R; Gabel S; Schaeverbeke J; Scheltens P; Blin O; Richardson JC; Bordet R; Wallin A; Eckerstrom C; Molinuevo JL; Engelborghs S; Van Broeckhoven C; Martinez-Lage P; Popp J; Tsolaki M; Verhey FRJ; Baird AL; Legido-Quigley C; Bertram L; Dobricic V; Zetterberg H; Lovestone S; Streffer J; Bianchetti S; Novak GP; Revillard J; Gordon MF; Xie Z; Wottschel V; Frisoni G; Visser PJ; Barkhof F
Alzheimers Res Ther; 2018 Sep; 10(1):100. PubMed ID: 30261928
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
[TBL] [Abstract][Full Text] [Related]
10. APOE ε4 is associated with disproportionate progressive hippocampal atrophy in AD.
Manning EN; Barnes J; Cash DM; Bartlett JW; Leung KK; Ourselin S; Fox NC;
PLoS One; 2014; 9(5):e97608. PubMed ID: 24878738
[TBL] [Abstract][Full Text] [Related]
11. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
Madusanka N; Choi HK; So JH; Choi BK; Park HG
Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
[TBL] [Abstract][Full Text] [Related]
12. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
[TBL] [Abstract][Full Text] [Related]
13. Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohort.
Teng E; Chow N; Hwang KS; Thompson PM; Gylys KH; Cole GM; Jack CR; Shaw LM; Trojanowski JQ; Soares HD; Weiner MW; Apostolova LG;
Dement Geriatr Cogn Disord; 2015; 39(3-4):154-66. PubMed ID: 25547651
[TBL] [Abstract][Full Text] [Related]
14. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
Liu G; Liu C; Qiu A;
Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
[TBL] [Abstract][Full Text] [Related]
15. Do multiple system atrophy and Parkinson's disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study.
Wang N; Zhang L; Yang H; Luo X; Fan G
Eur Radiol; 2019 Sep; 29(9):4948-4956. PubMed ID: 30796577
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
[TBL] [Abstract][Full Text] [Related]
17. Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.
Wang PN; Liu HC; Lirng JF; Lin KN; Wu ZA
Psychiatry Res; 2009 Mar; 171(3):221-31. PubMed ID: 19217759
[TBL] [Abstract][Full Text] [Related]
18. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
[TBL] [Abstract][Full Text] [Related]
19. Hippocampal subfield volumes in mild cognitive impairment and alzheimer's disease: a systematic review and meta-analysis.
Zhang J; Xie L; Cheng C; Liu Y; Zhang X; Wang H; Hu J; Yu H; Xu J
Brain Imaging Behav; 2023 Dec; 17(6):778-793. PubMed ID: 37768441
[TBL] [Abstract][Full Text] [Related]
20. Episodic Memory and Hippocampal Volume Predict 5-Year Mild Cognitive Impairment Conversion in Healthy Apolipoprotein ε4 Carriers.
Abraham M; Seidenberg M; Kelly DA; Nielson KA; Woodard JL; Carson Smith J; Durgerian S; Rao SM
J Int Neuropsychol Soc; 2020 Aug; 26(7):733-738. PubMed ID: 32131913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
